The Monitor

February 2012
Wherever the pursuit of clinical research takes us across this big blue marble of a world, it seems that globalization is simultaneously reducing the barriers to multinational studies and increasing their complexity, especially in terms of compliance and oversight. In the theme articles for this issue, international experts focus on bright spots in the clinical research enterprise that show how globalization confronts us in positive ways with the need for new ideas, updated best practices, and activity levels that keep pace with new technologies and increasing demands.